3D Printing for Manufacturing Regulated Products: FDA's Current Acceptance and Future Projections

The webinar will discuss the current available regulatory pathways to develop FDA-regulated 3D printed products and also predictions on what to expect in the near future. 3D printing in personalized treatments will be discussed and attendees will be provided practical tips for pursuing approval with the FDA.

Why Should You Attend:

3D printing offers the promise of easy and convenient custom manufacture of a variety of products. There have been several developments in the use of this technology to manufacture medical devices and even attempts to manufacture biologics and drugs.

Who Will Benefit:

Research and development personnel involved in 3D printed products

GMP and QSR personnel

Regulatory affairs personnel

Senior executives of pharmaceutical and device firms planning 3D printed products

Vice presidents, directors and managers

Instructor Profile:

Dr. Mukesh Kumar, is a Washington DC-based consultant in regulatory affairs and quality assurance for manufacturers and developers of FDA-regulated products. He leads the regulatory affairs and quality assurance departments at Amarex, a full service pharmaceutical product development company based in Germantown, MD. 

Note:

Use coupon code 232082 and get 10% off on registration.

For Registration:

http://www.complianceonline.com/developing-fda-regulated-3d-printed-manufacturing-products-webinar-training-703621-prdw?channel=sciencedz